TSE:SLF

Sun Life Financial Inc (SLF.TO)

102.80
+1.38 (1.36%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
720 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 12 opinions in the last 12 months.

Sun Life Financial Inc (SLF) is presently facing a challenging landscape, with mixed reviews from experts highlighting both the strengths and weaknesses of the company. Some analysts praise its strong management and growth potential in Asia, particularly in asset management, whereas others express concerns regarding its performance in the U.S. dental market and overall growth, particularly as compared to peers like Manulife Financial Corporation (MFC). Despite trading at a lower P/E ratio compared to Canadian banks, some experts argue that the stock's current valuation isn't compelling given the subdued growth prospects. However, SLF is recognized for its consistent dividend growth and stable earnings, and the recent share repurchases are seen as a positive move. Analysts are divided, with some asserting a long-term bullish outlook while others remain cautious pending macroeconomic or company-specific catalysts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
MFC
TOP PICK
Has been largely overlooked relative to Manulife (MFC-T). Could earn $3.50 this year and close to $4 next year. Management is taking steps to surface some of that value for shareholders by clearing up their US asset MFS. ROE has been consistently improving the last number of quarters and is currently over 13%.
TOP PICK
Technically, the Manulife (MFC-T) chart looks stronger, but this is statistically cheaper by about 1.5 times and has a better yield. International growth. An inexpensive, low risk way to play the Asian markets.
BUY
Banks have had a big move, so you could play the life insurance companies at this time.
DON'T BUY
Has had problems with their US financial services assets. He has reduced his holdings over the last year or so. Most of their areas are not growing.
TOP PICK
Although the numbers and growth aren’t as good as Manulife (MFC-T), it is an action oriented pick. They are shopping MFS, their US mutual fund arm and a really good deal could create $4/5 of value. Also expects 6/8% beyond that which could total 20% return.
COMMENT
Very interesting at these levels. Have had a lot of management turnover, which could be good. Trades at about 15 X earnings. Own a very large mutual fund complex in the US and think they will do something about this. Have a lot of cash.
DON'T BUY
Has had some problems and management has not been that responsive. Wouldn't buy at this price. Would consider at $42.
TOP PICK
It has had a few short term problems over the last year. ( lost a few good managers ) It is cheaper than Manulife. Believes that it should be part of everyones long-term portfolio.
TOP PICK
Has good earnings profile. Management has just taken steps for alternatives with their US funds to surface some of the underlying values.
HOLD
Mostly Canadian with a little bit UK and Asia. Stock has moved lately based on rumours they are going to do something with their US mutual fund holdings.
BUY
Canada's 2nd largest life insurance company. Has under performed its peers, mainly because of their very large US operation, Massachusetts Financial, a very large mutual fund company with poor results in the last few years. You can own as a turnaround story. Prefers Manufacturers (MFC-T).
BUY
Earnings where a little disappointing. Likes the company. Under performed Manulife (MFC-T) quite a bit so could do a little catch up. If they could spin out the US assets, this could add quite a bit of value to the company.
DON'T BUY
Have had a lot of problems with their US mutual fund with huge redemptions, big fine a year ago, etc. Also a big holder of CI Funds. If you strip out those 2, they still have a lot of problems in their insurance division compared to others.
HOLD
His favourite life insurance is Manufacturers (MFC-T) but this is also a great company.
PAST TOP PICK
(A Top Pick Aug 5/05. Up 0.1%.) Since it was recommended, its profitability has deteriorated. Fundamentals are not as appealing now.
Showing 706 to 720 of 1,049 entries